Candel Therapeutics (CADL) shares rose 3.9% in Monday trading after BofA upgraded the stock to buy from neutral.
Trading volume stood at 631,000 shares, compared with a daily average of about 1.4 million.
Price: $11.27, Change: $+0.42, Percent Change: +3.88%